Telmisartan
- Product NDC
- 67296-2284
- 11-digit product format
- 672962284
- Labeler code
- 67296
- Product ID
- 67296-2284_5743c596-7fcc-a9b5-e063-6294a90a2099
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Telmisartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Redpharm Drug
- Application
- ANDA203986
- Marketing category
- ANDA
- Marketing start
- 2025-12-01
- Substance
- TELMISARTAN
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203986-001 | TELMISARTAN | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | |
| A203986-002 | TELMISARTAN | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | |
| A203986-003 | TELMISARTAN | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203986-001 | AB |
| A203986-002 | AB |
| A203986-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | b8a1b40f171c… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-001 | TELMISARTAN | 20MG | TABLET / ORAL | AB | 2025-01-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-002 | TELMISARTAN | 40MG | TABLET / ORAL | AB | 2025-01-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-003 | TELMISARTAN | 80MG | TABLET / ORAL | AB | 2025-01-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203986-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A203986-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A203986-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A203986-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A203986-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A203986-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203986-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203986-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203986-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203986-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203986-003 | AB | 1 | b8a1b40f171c… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203986-003 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Telmisartan
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TELMISARTAN | 20 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U5SYW473RQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 282755 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5743c58e-deab-ac93-e063-6294a90ac1eb | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | Redpharm Drug | 5743c58e-deab-ac93-e063-6294a90ac1eb | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 203986 ANDA203986 67296-2284 |
| Telmisartan | TELMISARTAN | Macleods Pharmaceuticals Limited | 671d5a85-4146-43b4-9d7d-ca53268eb2a6 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 203986 ANDA203986 |
| Telmisartan | TELMISARTAN | NorthStar RxLLC | 9c22a318-d1f2-4788-9331-66fed71ebf38 | 2025-12-06 | Boxed warning, Warnings, Adverse reactions | 203986 ANDA203986 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 67296-2284-9 | 67296228409 | 90 TABLET in 1 CONTAINER (67296-2284-9) | 90 tablet | 2025-12-01 | No | No | Current |